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Abstract 
Determination of eumelanin and pheomelanin in melanomas that exhibit different pigmentation was 
carried using a solid-phase extraction (SPE) preparation method based on weak anion exchange 
chemistry. This extraction significantly enhanced the chromatographic profile obtained by reverse 
phase high performance liquid chromatography - diode array detection (RP-HPLC-DAD). The SPE 
method was developed using aqueous standards of melanin markers:  thiazole-2,4,5-tricarboxylic acid 
(TTCA), thiazole-4,5-dicarboxylic acid (TDCA), pyrrole-2,3-dicarboxylic acid (PDCA) and pyrrole-2,3,5-
tricarboxylic acid (PTCA) and non-pigmented cell lines spiked with those markers. An excellent average 
recovery, above 90%, was obtained for the four markers with a relative standard deviation below 7%. 
We have also optimized the stationary phase and the mobile phase (phosphate concentration and pH) 
to improve sensitivity and to reduce the analysis time. Elution of the four markers is achieved in 5 
minutes and total analysis of biological samples is completed in 15 minutes. The quantification limits 
for TDCA, TTCA, PDCA and PTCA are 60, 50, 47 and 48 ng/mL respectively. Furthermore, DAD detection 
improves the marker identification in complex matrices through the analysis of UV spectra. We have 
successfully applied this method to melanoma tumors and cells. Murine B16BL6 tumor are highly 
pigmented with mostly eumelanin (98.1 % of eumelanin) while human SK-MEL-3 tumor contain about 
30 % pheomelanin. B16BL6 and B16F10 are eumelanic cells lines and NHEM melanocytes contain about 
24 % of pheomelanin. 
Keywords: eumelanin, pheomelanin, melanoma tumors, solid-phase extraction (SPE), High 
performance liquid chromatography – diode array detection (HPLC-DAD)
 1. Introduction 
Skin, hair and eye color is determined by the quantity and ratio of eumelanin (EM) to pheomelanin 
(PM), the two classes of melanin [1–3]. Eumelanin is a black to brown insoluble pigment, whereas 
yellow to reddish-brown color and solubility in alkaline solvents characterize PM. These pigments also 
differ in their capacity of protection to ultraviolet (UV) exposure. While EM is known for its 
photoprotection action due to free-radical scavenging and broadband adsorption properties, PM is a 
pro-oxydant [4,5] with poor photoprotective potential [6]. Melanogenesis by definition is the 
production of the melanin pigments by melanocytes and starts with the production of dopaquinone 
from tyrosine, catalyzed by tyrosinase [7]. Pheomelanin is first synthetized in the presence of thiol 
compounds such as cysteine [8,9]. The reaction between cysteine and dopaquinone generate 5-S-
cysteinyldopa (5SCD) and 2-S-cysteinyldopa (2SCD), which are subsequently oxidized by dopaquinone 
and yield the pheomelanin monomer entity, benzothiazine, that is progressively converted to 
benzothiazol [10]. The reduction of cysteine concentration contributes to the spontaneous cyclization 
of the highly reactive dopaquinone to give rise to dopachrome. Dopachrome rearrangement produces 
5,6-dihydroxyindole (DHI) and 5,6- dihydroxyindole-2-carboxylic acid (DHICA). Tyrosinase-related 
protein 2 (Tyrp2) catalyzes the production of DHICA. Afterwards, both dihydroxyindoles are oxidized 
to form the eumelanin polymer. In mice, the tyrosinase-related protein (Tyrp1) oxidizes DHICA [7] and 
thus influences the degree of polymerization and the ratio DHI to DHICA in EM. 
Quantification of EM and PM is achieved by indirect methods. Specific melanin markers are obtained 
after fragmentation of melanin polymers under controlled conditions. The most common degradation 
method uses alkaline peroxide oxidation [12–14] or reductive hydroiodic acid hydrolysis [15]. The 
markers are then separated by HPLC. Eumelanin breakup with the alkaline hydrogen peroxide 
oxidation produces PTCA and PDCA molecules that are specific markers of DHICA and DHI moieties 
respectively (Figure 1A)  [12]. Additionally, under this treatment the pyrrole acids, pyrrole-2,3,4,5-
tetracarboxylic acid (PTeCA) and pyrrole-2,3,4-tricarboxylic acid (isoPTCA) can be detected. PTeCA  
reflects the cross-linking  at the C2 and C3 positions of the DHI moiety of eumelanin and isoPTCA  the 
cross-linking at the C3 position of DHI unit [16]. Pheomelanin is quantified through TTCA marker 
obtained from the benzothiazole monomer degradation, which also produces TDCA but in a low yield 
in comparison to TTCA (Figure 1B). If the treatment consists in a reductive hydroiodic acid hydrolysis, 
the specific marker 4-amino-3-hydroxyphenilalanine (4-AHP), originating from benzothiazine 
monomer, is used to measure the pheomelanin content. This reaction also generates the 3-amino-4-
hydroxyphenilalanine (3-AHP) but this one is less pheomelanin-specific [17].  
  
 
 
 
 
 
 
 
 
 
 
Figure 1. Eumelanin and pheomelanin markers obtained by alkaline peroxide oxidation. A) Peroxide oxidation of 
DHI and DHICA moieties of EM produces PDCA and PTCA markers respectively. B) Oxidation of the benzothiazole 
unit of PM yields TTCA and TDCA markers. 
The melanin markers can be synthetized through the methods reviewed  by d’Ischia et al. [18]. The 
main advantage of alkaline H2O2 oxidation is the simplicity of sample treatment in comparison with 
reductive HI hydrolysis. It furthermore permits quantification of the four melanin markers (PTCA, 
PDCA, TTCA and TDCA) in a single reverse phase HPLC analysis using a classical UV detector, while the 
determination of 4-AHP employs electrochemical detection and two separated HPLC sample injections 
in order to quantify eumelanin and pheomelanin. Although the alkaline hydrogen peroxide oxidation 
method can be easily implemented, separation and quantification of markers by HPLC can be 
complicated, especially in complex biological samples. For example in melanoma cells or tumors, 
interferences from matrices lead to co-elution problems or production of unresolved chromatographic 
peaks, making the interpretation of chromatograms difficult. Recently, Ito et al. [19] have proposed an 
acidic hydrolysis with 6M HCl at high temperature before alkaline oxidation, allowing protein removal 
from hair samples and simplification of the chromatograms. However, this procedure induces the 
decarboxylation of the DHICA [20] and benzothiazole moieties and therefore modifies melanin 
markers concentrations. For example, PTCA, the marker used to quantify EM is approximately 50% 
reduced after strong acidic hydrolysis of natural hair melanins and fully reduced in synthetic DHICA 
melanins. In the case of pheomelanin markers, TDCA concentration increases significantly and TTCA 
drops to 37% in hair melanin [19]. 
 Here we propose a SPE preparation method based on weak anion exchange chemistry prior to RP-
HPLC, which significantly improves the chromatographic profile. Using two different C18 columns, we 
also evaluated analytical conditions, pH and phosphate buffer concentration in the mobile phase in 
order to decrease analysis time and improve sensitivity. We analyzed the UV response of each marker 
and optimized the detection wavelength by the use of the diode-array detection HPLC. Marker 
identification in complex matrices is significantly enhanced through the evaluation of UV spectra and 
the purity of the chromatographic peaks. We also show that the method can be successfully applied 
to different pigmented human and murine melanoma tumors and cell lines.  
2. Material and methods  
2.1 Reagents and standards 
Phosphoric acid (49-51%), hydrogen peroxide ( 30%) and chlorhydric acid were provided from Fluka, 
France. Methanol (HPLC-PLUS-Gradient) was provided from Carlo Erba, Peypin, France. Monobasic 
sodium phosphate, sodium sulfite, sodium acetate, potassium hydroxide and synthetic melanin 
standard were purchased from Sigma-Aldrich, France. 25% ammonia solution for LC-MS was from 
Merck, Germany. Melanin standard markers: PTCA, PDCA, TDCA, TTCA were kindly provided by Dr. Ito 
and Dr. Wakamatsu (Fujita Health University School of Health Sciences, Toyoake, Aichi Japan). An 
aqueous stock solution containing 100 μg/mL of four melanin markers was prepared and stored at −20 
°C. Other working standard solutions were prepared by dilution of stock solutions.  
2.2 Samples 
Murine melanoma B16BL6 cells were sourced from Professor Fidler’s lab (Texas University, Houston, 
USA). Murine melanoma B16F10 cells and human melanoma SK-MEL-3 cells were purchased from 
ATCC (Manassas, USA). Human melanoma A375 cells were purchased from ECACC (Salisbury, UK). 
Normal Human Epidermal Melanocytes (NHEM) from juvenile foreskin of a Caucasian male were 
purchased from PromoCell (Heidelberg, Germany). B16BL6 and B16F10 cells were maintained as 
monolayers in Dulbecco’s Modified Eagle’s Medium (DMEM-Glutamax, Life Technologies, 
Courtaboeuf, France) supplemented with 10% fetal calf serum (FCS, Eurobio, Courtaboeuf, France) and 
4 µg/mL gentamycin (Life Technologies, Courtaboeuf, France). A375 cells were cultured in DMEM 
supplemented with 15% FCS and 4 µg/mL gentamycin. SK-MEL-3 cells were cultivated in McCoy’s 5A 
Medium (Invitrogen) with 15% FCS and 4 µg/mL gentamycin. Normal Human Epidermal Melanocytes 
were maintained in Melanocyte Growth Medium M2 (Promocell) with Supplement Mix (Promocell) 
and 10 000 U/mL penicillin - 10 000 µg/mL streptomycin. Cells were grown at 37°C in a humidified 
incubator with 5% CO2. Syngenic B16BL6 tumors were obtained after subcutaneous injection of 
 melanoma cells into the flank of C57BL/6J mice [21]. SK-MEL-3 human tumor xenografts were obtained 
after subcutaneous injection into the flank of male Swiss nu/nu mice as previously described [12]. 
2.3 Sample preparation 
Samples were submitted to an alkaline H2O2 oxidation to obtain melanin markers as described by Ito 
et al. [12] with some modifications. 
2.3.1 Tumour samples 
About 10 mg of tumors were weighed into a gentleMACS M tube (Gentle MACS Dissociator, Miltenyi 
Biotec, Paris, France) and 500 µL of 1 mol/L KOH were added. Tumors were then homogenized using 
the pre-set gentleMACS™ Dissociator program m_heart_01.01. Homogenized samples were 
transferred into a 15 mL screw-capped conical tube. A volume of 100 µL was reserved for total melanin 
quantification at 405 nm using a standard curve generated from known concentrations of synthetic 
melanin. 25 µL of H2O2 were added (final concentration 1.5% v/v) to the remaining 400 µL  and closed 
tubes were shacked overnight at 25°C. 50 µL of 10% (w/v) Na2SO3 were added to decompose residual 
H2O2  and samples were acidified by addition of 200 µL of 1 mol/L HCl. Samples were filtered with 
regenerated cellulose syringe filters (0.22 µm , Phenomenex). 
2.3.2 Cell samples 
The cell pellets of B16BL6 and B16F10 cell lines consisted of approx. 4.106 cells and the NHEM 
melanocyte pellets of 1.5 to 2.106 cells. A volume of 100 µL of 1 mol/L KOH was added for every 1.106 
cells.  After homogenization with vortexing,  50 µL was reserved for total melanin quantification at 405 
nm using a standard curve generated from known concentrations of synthetic melanin. Next, the 
oxidation reaction was performed by addition of H2O2 to a final concentration of 1.5% v/v, followed by 
an overnight incubation at 25°C. Remaining peroxide was quenched by addition of a volume of 10% 
(w/v) Na2SO3 corresponding to twofold the H2O2 volume. The pH of the samples were adjusted to 3.3 
by addition of 1 mol/L HCl. Samples were filtered with regenerated cellulose syringe filters  (0.22 µm, 
Phenomenex). 
2.4 Solid phase extraction  
Prior to the sample extraction, SPE cartridges (Strata-X-AW 33µm polymeric weak anion 30mg/1mL, 
Phenomenex) were conditioned with 500 µL of acetonitrile and 500 µL of 100 mmol/L sodium acetate 
pH 5.2. Extracts of tumor samples were loaded onto the column prior to dilution 1:1 with 100 mmol/L 
sodium acetate pH 5.2. Samples were eluted from the column at a reduced flow rate followed by a 
column wash step with 500 µL of 100 mmol/L sodium acetate pH 5.2 and 500 µL of acetonitrile. The 
 cartridge was then dried under vacuum for 5 minutes. The SPE column was eluted twice with 500 µL 
of 5% (v/v) aqueous NH4OH. Extracts were lyophilized overnight (Freeze Dryer/Lyophilisator Alpha 2-4 
LD Plus, Christ, Germany) and reconstituted with 200 µL of 20 mmol/L aqueous potassium phosphate 
pH 3.3. Recoveries were calculated from at least three replicate measurements of each concentration 
in aqueous solutions of a standard mix containing PTCA, PDCA, TDCA and TTCA and spiked A375 cells 
using independent cartridges.  
2.5 High performance liquid chromatography conditions 
HPLC-DAD analysis conditions were determined by comparing two different C18 columns. Column 1 
consisted of a Kinetex Evo C18, 150 x 3 mm, 2.6 µm particle size, 100 Å pore size from Phenomenex 
fitted with a SecurityGuard™ ultra LC filter 0.2µm (Phenomenex). Column 2 was a Gemini C18, 150 x 3 
mm, 3 µm particle size, 100 Å pore size (Phenomenex) with a SecurityGuard™ cartridge for Gemini C18. 
The HPLC system was an Agilent 1200 HPLC separation module equipped with an online degasser, a 
quaternary pump, an automatic sampler, a thermostatic controlled column chamber and a DAD 
detector. The system was controlled by OpenLab CDS Agilent software version A.01.05. Separation of 
eumelanin (PDCA and PTCA) and pheomelanin (TDCA and TTCA) markers was obtained using 20 mM 
aqueous potassium phosphate pH 3.3 (A) and 100% methanol (B) as mobile phase, 0.6 mL/min flow 
rate and 36°C column temperature. The elution program differed for column 1 and 2. For column 1 the 
program starts from 0 to 6 min at 0% B isocratic, followed by 6-7 min linear gradient from 0% to 10% 
B for column cleaning and finally a re-equilibration period for 7-15 min with 0% B. The elution program 
use for column 2 was: 0 to 12 min 0% B isocratic, followed by 12-15 min linear gradient from 0% to 
10% B for column cleaning and finally a re-equilibration period 15-25 min with 0% B. For both columns, 
the injection volume was 20 μL, and detection wavelengths were set a 225 and 275 nm for PTCA and 
TTCA, 254 nm for TDCA and 280 nm for PDCA. The UV spectra of reference compounds were recorded 
and integrated into an UV library. Spectra were used to confirm the identity of markers in biological 
samples. Total eumelanin was obtained by multiplying total PTCA by a factor of 60 for murine and 80 
for human tumors. To convert TTCA to pheomelanin, TTCA was multiplied by a factor of 34 [12].  
2.6 Validation of the HPLC method 
Calibration curves were constructed in concentrations ranging from 0.25 to 10 µg/mL. The limits of 
detection (LOD) and quantification (LOQ) were calculated using LOD = 3.3(SD/S) and LOQ = 10(SD/S) 
respectively, where S is the slope and the SD is the residual standard deviation of calibration curves. 
To evaluate reproductibility, we used SD from three separated injections of markers that were realized 
on the same day.  
 
 3. Results and Discussion 
3.1 Chromatographic condition optimization 
To select the best stationary phase for melanin marker analysis, we chose to evaluate two octadecyl 
columns, which differ in the particle nature. Column 1 has core-shell particles (i.e a nonporous core 
inside a porous shell with a total diameter of 2.6 µm. Kinetex EVO C18, Phenomenex) and column 2 
has fully porous particles of 3 µm diameter (Gemini C18, Phenomenex). Both columns tolerate 100% 
water. The mobile phase phosphate at 100 mM and pH 2.1 was used based on previously published 
results [12]. One of the goals was to optimize pH and concentration of the phosphate buffer in the 
mobile phase. A low concentration of phosphate allowed column-cleaning step with organic solvent 
after elution of melanin markers to avoid a contaminant carry-over from a previous injection. In 
addition, the salt precipitation risk is reduced at the column level, and also in the pump and HPLC 
valves. Peak shape analysis and retention time of melanin standard markers (10 g/mL) obtained with 
100, 70, 50, 30 and 20 mM phosphate buffer are illustrated in Table 1.  
Table 1. Chromatographic peak performances of TTCA, PTCA, TDCA and PDCA standards using 10 
µg/mL solutions. 
 
Values were calculated as means (standard deviation) of n=3. Area enrichment was calculated as the percentage of the difference between 
peak area at the maximum wavelength and peak area at 275 nm (obtained with 20 mM phosphate pH 3.3) 
Marker 
Wavelength 
(nm) 
Phosphate 
pH 
Phosphate 
concentration 
(mmol/L) 
Retention 
Time (min) 
Area 
(mAU*s) 
Area 
enrichment 
(%) 
Symmetry 
(USP at 10% 
height) 
TTCA 
275 2.1 
100 2.30 (0.13) 139 (12) 
 
1.84 (0.04) 
70 2.22 (0.01) 128.2 (0.1) 
 
2.20 (0.01) 
50 2.28 (0.01) 104 (16) 
 
2.04 (0.04) 
30 2.38 (0.01) 121.4 (0.3) 
 
2.12 (0.02) 
20 2.52 (0.02) 121.0 (0.4) 
 
2.22 (0.02) 
275 
3.3 
20 2.14 (0.01) 116 (1) 
 
2.02 (0.04) 
225 20 2.14 (0.01) 203 (1) 75 2.03 (0.03) 
PDCA 
275 2.1 
100 2.89 (0.01) 243 (3) 
 
1.47 (0.01) 
70 2.88 (0.01) 240.7 (0.2) 
 
1.44 (0.03) 
50 2.90 (0.01) 242 (3) 
 
1.42 (0.03) 
30 2.95 (0.01) 246 (1) 
 
1.43 (0.01) 
20 3.04 (0.01) 250.3 (0.4) 
 
1.43 (0.02) 
275 
3.3 
20 2.36 (0.01) 254.8 (0.5) 
 
1.30 (0.02) 
280 20 2.77 (0.01) 278.1 (0.8) 9 1.30 (0.02) 
TDCA 
275 2.1 
100 3.3 (0.2) 90 (6) 
 
1.30 (0.04) 
70 3.23 (0.01) 86.3 (0.3) 
 
1.28 (0.02) 
50 3.28 (0.01) 84 (7) 
 
1.35 (0.03) 
30 3.37 (0.01) 89.9 (0.1) 
 
1.33 (0.06) 
20 3.51 (0.01) 91.0 (0.7) 
 
1.30 (0.03) 
275 
3.3 
20 3.22(0.01) 73.6 (0.2) 
 
1.19 (0.03) 
254 20 3.22 (0.01) 228.8 (0.5) 210 1.76 (0.02) 
PTCA 
275 2.1 
100 5.02 (0.24) 186 (10) 
 
1.07 (0.01) 
70 4.86 (0.01) 176.4 (0.1) 
 
1.08 (0.01) 
50 4.95 (0.01) 174 (3) 
 
1.05 (0.01) 
30 5.03 (0.01) 178 (1) 
 
1.08 (0.01) 
20 5.22 (0.04) 177 (1) 
 
1.07 (0.01) 
275 
3.3 
20 4.22 (0.01) 163.9 (0.1) 
 
1.17 (0.02) 
225 20 4.22 (0.01) 288 (2) 76 1.18 (0.02) 
 
 The data indicates that peak shape (symmetry) for PDCA, TDCA and PTCA detected at 275nm remains 
the same independently of phosphate concentration at pH 2.1. Diminution of phosphate concentration 
slightly increased retention times. The pheomelanin marker, TTCA, was the most affected by the 
reduction of phosphate concentration with a symmetry value of 1.84 at 100 mM and 2.22 at 20 mM 
phosphate pH 2.1. When a 20 mM pH 3.3 phosphate mobile phase is used instead of pH 2.1, the 
retention times of the four markers are reduced and the symmetry of TTCA peak reached 2.02, 
considered as an acceptable limit [22,23]. Chromatographic data were recorded in the range of 200 to 
400 nm. Finally, PTCA and TTCA peaks were integrated at 225 and 275 nm respectively, PDCA at 280 
nm and TDCA at 254 nm, which correspond to the maximum of absorbance wavelengths of each 
melanin marker (Figure 2C to 2F). Measurement at the specific wavelengths improves the detection as 
shown by the peak area enrichment of 75, 9, 210 and 76 % obtained for TTCA, PDCA, TDCA and PTCA 
respectively in comparison to the signal recorded at 275nm. A good separation is obtained with 20 mM 
pH 3.3 phosphate mobile phase delivered at 0.6 mL/min and column 1 maintained at 36°C (Figure 2A). 
The use of the fully porous column with the same mobile phase and elution conditions produced an 
excellent separation of the four markers (Figure 2B).  
 
Figure 2. RP-HPLC-DAD chromatograms of a mixture of four melanin markers (10µg/mL) obtained with 20mM 
phosphate pH 3.3 as mobile phase at 0.6 mL/min, 36°C, signal detected at 275nm and 5µL injection volume. A) 
Column: Kinetex Evo C18, 150 x 3 mm, 2.6 µm particle size, 100 Å pore size from Phenomenex B) Column: Gemini 
C18, 150 x 3 mm, 3µm particle size, 100 Å pore size, Phenomenex C) TTCA UV- spectrum D) PTCA UV- spectrum 
E) TDCA UV- spectrum and F) PDCA UV- spectrum 
However, the duration of analysis increased three-fold. The analysis time reduction with the core-shell 
particles is in accordance with the particle morphology favoring a quick mass transfer from the mobile 
phase through to the outer layer of stationary phase and back again. Validation of the method under 
the optimized conditions for the core-shell and fully porous column is presented in Table 2. Calibration 
curves were linear for all markers between 0.25 and 10 µg/mL with r  0.9999. The calculated limit of 
 detection and quantification (LOD and LOQ) were similar for both column over the range from 0.015 
to 0.020 µg/mL for the core-shell column and from 0.013 to 0.016 µg/mL for the fully porous column.  
Table 2. Validation of the method with respect to linearity of calibration, retention time of the four 
melanin markers studied.  
Values were calculated as means of n = 3 
*Retention times of standards at 10 µg/mL, injection volume of 20µL 
LOD: limits of detection calculated as LOD = 3.3(SD/S); LOQ: limits of quantification; calculated as LOQ = 10(SD/S); RSD (%): percentage 
relative standard deviation. 
The first line corresponds to results obtained with Kinetex EVO C18 column and the second with the Gemini C18 column 
 
3.2 SPE extraction optimization of standards  
In order to take into account the ionization capacity of melanin markers at basic pH, a weak anion 
exchange extraction was realized. Analytical conditions are critical for satisfactory elution and recovery 
of compounds in SPE. For that we first tested the extraction method using aqueous melanin standards. 
Strata-X-AW 33µm cartridges were selected to provide relatively high recoveries due to their capacity 
of interaction with acidic compounds (pKa<5) as the sorbent consists of a weak anion polymer. In 
addition, the polymer tolerates a wash step with 100% of organic solvent. For the first step, the sorbent 
was conditioned with 100% acetonitrile and 100 mmol/L sodium acetate pH 5.2. At this pH, at least 
one acidic function of melanin markers loses a proton and is retained by the sorbent. The elution step 
was performed comparing 5% (v/v) aqueous NH4OH and 5% (v/v) NH4OH in 95% methanol or 
acetonitrile. Direct HPLC injection of extracts after adjustment to pH 3.3 produces deformed 
chromatographic peaks (data not shown), principally due to composition differences between sample 
solvent and mobile phase. To overcome these problems, extracts were lyophilized overnight and 
reconstituted with the mobile phase before injection. Lyophilisation of aqueous NH4OH is easier to 
handle in contrast to organic solvents since sample freezing is achieved at -20°C. Another advantage 
of reconstitution of lyophilized extracts is the possibility of pre-concentration of analytes, in case of 
samples with low melanin content. The recovery results of aqueous standard solution were calculated 
by comparison of analyte amounts obtained after extractions and those in the initial working solutions. 
Average recovery at 2 and 4 g/mL (Table 3) exhibit very high recovery values between 91 and 96%, 
with an RSD between 5 to 7%.  
Markers 
(Wavelength, 
nm) 
Linearity 
range 
(µg/mL) 
Retention 
time (RT) * 
(min) 
Regression equation 
Correlation 
(r2) 
LOD 
(µg/mL) 
LOQ 
(µg/mL) 
%RSD 
(RT) 
%RSD 
 (peak 
area) 
TTCA (225) 0.25-10 
2.13 
5.11 
y = 663.119X + 1.347 
y = 66.536x – 0.791 
1.0000 
1.0000 
0.017 
0.016 
0.050 
0.048 
0.03 
0.10 
0.17 
0.03 
PDCA (280) 0.25-10 
2.80 
6.34 
y = 119.861x -1.2203 
y = 129.436x -1.595 
1.0000 
1.0000 
0.015 
0.014 
0.047 
0.041 
0.04 
0.06 
0.27 
0.06 
TDCA (254) 0.25-10 
3.26 
7.85 
y = 87.620x – 2.299 
y = 88.175x – 0.713 
1.0000 
1.0000 
0.020 
0.013 
0.060 
0.039 
0.02 
0.06 
0.06 
0.04 
PTCA (225) 0.25-10 
4.34 
12.23 
y = 115.390x +1.063 
y = 119.803x -1.269 
1.0000 
1.0000 
0.016 
0.013 
0.048 
0.040 
0.05 
0.06 
0.39 
0.03 
 Table 3. Recoveries obtained by SPE from aqueous solutions of standards containing PTCA, PDCA, TDA 
and TTCA at 2 and 4 µg/mL. 
 
 
 
 
 
3.3 SPE extraction in spiked biological samples 
The SPE extraction was performed using fortified depigmented cell extracts (A375 cell lines) at 1, 2 and 
5 µg/mL. HPLC-DAD analysis of all fractions from the different steps of SPE extraction was performed 
and compared to the untreated sample analysis. Satisfactory recovery values for TTCA, PTCA, PDCA 
and TDCA standards were obtained (97.8; 97.7; 99.1 and 103.4% respectively with RSD  5.6%) for the 
spiked depigmented cell line samples (Table 4), validating the use of weak anion exchange SPE method 
fo r the analysis of melanin markers in biological matrix. 
Table 4. Recoveries obtained after SPE from spiked A375 cells at three concentrations. 
  
 
Expected 
mass (µg) Measured mass (µg) Recovery (%) 
TTCA 
0.877 0.881 100.4 
2.196 2.105 95.8 
4.393 4.266 97.1 
mean   
 97.8 
SD   
 2.4 
RSD (%)  
 2.4 
PTCA 
1.003 1.041 103.9 
2.511 2.350 93.6 
5.022 4.804 95.7 
mean    97.7 
SD    5.4 
RSD (%)   5.6 
PDCA 
0.989 1.041 102.9 
2.478 2.350 96.9 
4.955 4.804 97.5 
mean    99.1 
SD    3.3 
RSD (%)   3.4 
TDCA 
0.980 0.980 100.0 
2.454 2.580 105.1 
4.908 5.160 105.1 
mean    103.4 
SD    3.0 
RSD (%)     2.9 
  
Concentration  
(µg/mL) 
% Recovery 
TTCA PDCA TDCA PTCA 
2 
87.6 89.2 85.9 86.4 
98.4 100.2 99 98.9 
87.3 91.3 88.8 88.6 
4 
87.7 91.6 86.9 87.0 
99.0 101.8 92.6 94.2 
102.0 104.2 93.8 97.6 
mean 93.7 96.4 91.2 92.1 
STD 6.8 6.4 4.9 5.5 
RSD (%) 7.3 6.6 5.4 6.0 
 Chromatograms of untreated samples and the elution SPE fraction of non–spiked and spiked A375 
samples are presented in Figure 3. Chromatograms of untreated samples (Figure 3A) present weak 
retained compounds with high response signals of about 2000 mAU. In Figure 3B, chromatogram 
overlay of a sample before and after SPE shows that SPE disminishes large quantities of highly polar 
products that are weakly retained by the stationary phase. A peak at 8.30 min that co-eluted with TDCA 
is totally removed after SPE extraction, as are small interference peaks at the retention time of TTCA 
(5.42 min). Figures 3C and 3D allow the comparison of a crude sample before SPE and the sample 
spiked with a mixture of four markers at a concentration of 1 µg/mL after SPE. This comparison shows 
that melanin standard peaks are well separated from minor matrix sample peaks that remain after SPE 
extraction. All together, these results demonstrate the improvement of the chromatographic profile 
using SPE extraction. The remaining peaks after SPE extraction, other than melanin standards, are 
probably ionic compounds that have very similar UV spectra with a maximum of absorption around 
254nm.  
 
Figure 3. Chromatograms obtained by RP-HPLC-DAD (Column: Gemini C18, 150 x 3 mm, 3µm particle size, 100 Å 
pore size, Phenomenex) of A375 non-pigmented cells. A) crude sample before SPE method. A break was 
introduced in the x-axis and note the differences in y-axis scales. B) overlay of a crude sample before and after 
SPE. C) overlay of a crude sample before SPE and a spiked sample with a mixture of four markers (at a 
concentration of 1 µg/mL) after SPE. D) zoom of chromatogram C that shows the zone of interest between 5 and 
15 min of analysis. 
 
 
 3.4 Application to melanoma samples 
The analysis of eumelanin and pheomelanin in melanoma cells and tumors was then achieved with the 
validated method. In Figure 4, we present an example of a chromatogram of a SK-MEL-3 pigmented 
tumor. Figure 4A shows the reduction of matrix peaks after SPE. Focus in analysis time between 1.5 
and 2 min (Figure 4B) highlights the TTCA markers present in SK-MEL-3 samples. Different detection 
wavelengths and UV spectrum library of melanin markers were used to confirm the identity of markers. 
The correlation of UV spectra between reference standards and markers in samples is expressed as a 
match factor (values from 0 to 1000). To confirm the peak identity we fixed the match factor upper 
limit to 970, corresponding to 97.0% peak purity. For Figure 4B, the match factor of peaks in the load 
and elution fraction that have the same retention time as TTCA are 905 and 996.5 respectively, 
confirming the presence of TTCA in the elution fraction and the removal of interference in the load 
fraction. The PTCA peak at 4.2 min is detected in the elution fraction.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Chromatograms of SK-MEL-3 tumor obtained by RP-HPLC-DAD (column: Kinetex Evo C18, 150 x 3 mm, 
2.6 µm particle size, 100 A pore size from Phenomenex ) after SPE: ___  fraction obtained during sample loading,  
___Elution-fraction, ___UV spectrum of standards,  UV−−−
−−−  spectrum of the sample. A) Chromatograms between 
0 and 6 min of analysis corresponding to maximum elution time of melanin markers B) Zoom between 1.5 and 3 
min corresponding to the TTCA elution zone C) Zoom between 3 and 5 min of analysis corresponding to the PTCA 
elution zone. 
We use the previously reported factors of 34 to convert TTCA to pheomelanin and 80 for conversion 
of PTCA into eumelanin [12], for human melanoma samples. We find a good positive ratio (0.91 +/-
 0.22; n=10) between EM+PM obtained by HPLC and total melanin measured by the standard 
spectrophotometric method at 405nm, indicating a good fit of the conversion factor employed. 
However, for murine tumors the best fit was obtained when eumelanin was calculated by multiplying 
PTCA by a factor of 60 (EM+PM/TM of 1.04 +/- 0.25) instead of 80 (EM+PM/TM of 1.35 +/- 0.35). The 
PTCA conversion factor is subject to several variables such as DHI/DHICA ratio in EM, which can be 
modified by the Tyrp activity. We hypothesize that the variation comes from a different ratio of 
DHI/DHICA in melanoma tumors between mice and humans.   
The determination of EM and PM in melanoma tumors and cells of different pigmentation is presented 
in Figures 5A and 5B respectively. B16BL6 murine melanoma tumors are highly pigmented with 98.2 % 
of eumelanin. In parallel, TTCA was below of the detection limit for the B16BL6 cells, highlighting the 
eumelanic pigmentation of this cell line. Similarly, the murine B16F10 cell line is mainly eumelanic but 
it is 35% less pigmented, although this difference is not perceived visually. These results are in 
agreement with the literature on cells from C57BL/6J black mice which contain mostly the EM pigment 
[15,24,25]. Less pigmented SK-MEL-3 human melanoma tumors and NHEM cells contain about 30% 
and 24% of pheomelanin respectively. The obtained percentage of pheomelanin in SK-MEL-3 tumors  
and NHEM can be compared to recent published data of melanin content in human epidermis that 
show approximately 26 % of pheomelanin and 74% of eumelanin independently of the degree of 
pigmentation [26].  
 
 
 
 
 
 
 
 
 
 
Figure 5. Content of eumelanin and pheomelanin in:  A) murine melanoma tumors B16BL6 (n=10) and human 
melanoma tumors SK-MEL-3 (n=10); B) murine melanoma cells B16BL6 (n=2), B16F10 (n=2) and human 
melanocytes (n=4). 
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 A good correlation (r2 = 0.7849 and 0.9046; P <0.0001) is observed between total melanin obtained by 
chemical degradation method followed by SPE and HPLC analysis and total melanin measured by 
spectrophotometric method after potassium hydroxide solubilization for tumors and cells (Figure 6A 
and 6B), another indication of the good fit of the employed conversion factors.  
 
Figure 6. Correlation between total melanin obtained by chemical degradation method followed by SPE and HPLC 
analysis (eumelanin EM, and pheomelanin PM) versus total melanin (TM) content after potassium hydroxide 
solubilisation measured at 405nm. A) Melanoma tumors B16BL6 (n=10) and human melanoma tumors SK-MEL-
3 (n=10); B) murine melanoma cells B16BL6 (n=2), B16F10 (n=2) and human melanocytes (n=4). Correlation are 
significant at P < 0.0001. 
In order to confirm the advantages of the developed SPE-HPLC method, we present in Table 5 the 
comparison of results obtained after the analysis of melanoma tumors (B16BL6 and SK-Mel-3) and cell 
lines (B16BL6, B16F10 and human melanocytes) with and without SPE. The match factors between UV 
spectra of TTCA and PTCA markers of standards and samples are presented in heat map form. We fix 
minimum, middle and upper match factor limits at 960, 970 and 990 respectively. We show that match 
factors of chromatographic peaks corresponding to the retention time of TTCA obtained without SPE 
for SK-MEL-3 tumors are between 860 and 967, indicating the low purity produced by co-elution of 
matrix compounds. The TTCA marker was not detectable in the NHEM cells in this condition. After SPE 
 
A 
B 
 treatment of the same sample, we observe an excellent improvement of TTCA match factors to 968 to 
999, reflecting the elimination of matrix interferences. In the case of NHEM cells, the TTCA becomes 
quantifiable and is unambiguously identified (match factor 974 to 999). The impact of SPE is less 
pronounced for the PTCA marker. Notwithstanding, improvements are evident in the analysis of 
B16BL6 and B16F10 cell lines, resulting in a best match between the melanin detected by HPLC after 
SPE and the total melanin measured by  the spectrophotometric method. 
Table 5. Comparison of melanin content in tumor and cells samples after HPLC analysis with and 
without the developed SPE method. 
 Values of EM, PM, EM+PM and Total melanin at 405 nm are expressed in µg/mg tumor or µg/106 cells 
 Match factor between UV spectra of melanin markers standards and markers in sample is presented in heat map form. 
Minimum, middle and upper limit were fixed at 960, 970 and 990, respectively. 
 <LOD below the limit of detection 
 
4. Conclusions  
Weak anion exchange solid-phase extraction offers a consistent, inexpensive and suitable preparation 
method to improve eumelanin and pheomelanin determination in melanomas with high recoveries 
(97 to 103%) of melanin markers and good precision (RSD  5.6%). The optimized HPLC-DAD method 
increases the detection sensitivity of melanin markers, with detection limits ranging from 0.015 to 
0.020 µg/mL. This method reduces the time of analysis and enables a decrease of solvent consumption, 
since complete marker elution is achieved in 5 min and the total analysis of complex samples is 
accomplished in 15 min.   
UV
match
Aire 
(mAU*s)
match
Aire 
(mAU*s)
match
Aire 
(mAU*s)
match
Aire 
(mAU*s)
Tumor B16L6 #1 929.1 997.4 839 27.16 27.16 972.0 26.4 0.32 998.0 2024 23.84 24.16 23.05 1.3 98.7
Tumor B16BL6 #2 860.4 996.7 815 26.95 26.95 968.1 38.4 0.47 995.7 2075 24.96 25.43 17.53 1.8 98.2
Tumor B16BL6 #3 919.4 993.2 889 26.39 26.39 978.8 37.8 0.38 997.1 2280 22.57 22.95 18.39 1.7 98.3
Tumor  SK-MEL-3  #1 966.8 37.4 1.13 991.8 99 3.94 5.07 998.9 209.9 2.12 996.9 427 5.64 7.76 8.81 27.3 72.7
Tumor SK-MEL-3  #2 962.0 993.1 189 8.56 8.56 998.5 186.5 2.34 997.1 419 6.89 9.23 9.27 25.4 74.6
Tumor SK-MEL-3  #3 960.5 991.9 232 10.99 10.99 999.1 292.5 3.85 997.3 556 9.58 13.42 14.51 28.7 71.3
Cell B16BL6 #1 <LOD 978.2 133 15.22 15.22 <LOD 994.5 719 14.16 14.16 11.00 100
Cell B16L6 #2 <LOD 982.8 112 11.86 11.86 <LOD 989.9 429 8.66 8.66 8.71 100
Cell B16F10 #1 <LOD 968.7 63 6.20 6.20 <LOD 997.4 210 4.16 4.16 4.26 100
Cell B16F10 #2 <LOD 965.3 62 6.03 6.03 <LOD 995.6 205 4.00 4.00 4.12 100
Cell MHEN #1 <LOD 996.3 181 33.4 33.38 998.5 245.9 7.82 995.3 711 29.6 37.46 19.58 20.9 79.1
Cell MHEN #2 <LOD 992.3 173 23.3 23.27 992.4 174.6 5.60 992.2 426 17.9 23.48 14.27 23.9 76.1
Cell MHEN #3 <LOD 993.0 199 28.1 28.08 992.3 208.4 6.61 993.1 545 22.6 29.25 14.06 22.6 77.4
Cell MHEN #4 <LOD 990.4 229 50.8 50.75 973.9 107.2 7.26 992.3 209 18.5 25.76 11.408 28.2 71.8
Total 
melanin 
405 nm
%PM %EM
Sample
PM EM PM+EM PM
HPLC without SPE HPLC with SPE
TTCA PTCA TTCA PTCA
EM PM+EM
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